[et_pb_section fb_built=”1″ admin_label=”Advocacy T-Hero Section” module_class=”hero tert” _builder_version=”4.18.0″ _module_preset=”default” background_image=”https:\/\/aafa.org\/wp-content\/uploads\/2022\/07\/AAFA-Website_Tertiary_Advocacy.jpg” background_position=”top_right” custom_padding=”1%||1%||true|false” global_module=”2187″ saved_tabs=”all” locked=”off” collapsed=”on” global_colors_info=”{}”][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” background_enable_image=”off” background_size=”initial” background_position=”bottom_left” background_horizontal_offset=”0%” custom_margin=”||||false|false” custom_padding=”2%||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Nav Parent Title” module_class=”tert-parent” _builder_version=”4.17.4″ _module_preset=”default” header_2_font=”|600|||||||” header_2_text_align=”left” header_2_text_color=”#FFFFFF” header_2_font_size=”32px” custom_margin=”||0px||false|false” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][et_pb_code admin_label=”Breadcrumbs” module_class=”bcrumb” _builder_version=”4.17.4″ _module_preset=”default” text_orientation=”left” custom_margin=”||||false|false” custom_padding=”||||false|false” custom_css_main_element=”font-size:16px;||color: #fff;” global_colors_info=”{}”][\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Main Content” _builder_version=”4.17.4″ _module_preset=”default” background_enable_image=”off” background_size=”initial” background_position=”bottom_right” custom_padding=”2%||2%||true|false” global_colors_info=”{}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”H2 + Intro Content” module_class=”secondary-intro” _builder_version=”4.18.0″ _module_preset=”default” text_text_color=”#505050″ text_font_size=”28px” text_line_height=”1.5em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” custom_margin=”||3%||false|false” global_colors_info=”{}”]<\/p>\n
\u200bPeople with asthma and food allergies need access to affordable health insurance and to the medications and devices they need at affordable prices.\u00a0<\/p>\n
[\/et_pb_text][et_pb_text admin_label=”H3 + Content” _builder_version=”4.18.0″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on|||#008c99|” link_text_color=”#008c99″ header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” header_3_font=”|600|||||||” header_3_text_align=”left” header_3_text_color=”#008c99″ header_3_font_size=”28px” global_colors_info=”{}”]<\/p>\n
Individuals and families managing food allergies must often bear a heavy and rising cost burden for epinephrine auto-injectors (EAIs).1<\/sup>\u00a0 Similarly, people with asthma face large financial barriers to certain drugs.\u00a0 In AAFA\u2019s “My Life with Asthma” report,<\/a> only one in four respondents always used their asthma treatments as prescribed. The top three reported reasons for not using treatments were related to cost: inability to afford treatment, treatment was too expensive, and lack of insurance coverage for the treatment.2<\/sup>\u00a0 High out-of-pocket costs hinder adherence, threaten the health of patients, and exacerbate disparities in health status.<\/p>\n AAFA supports policies that reduce the cost burden of drugs for patients. AAFA supports:<\/p>\n [\/et_pb_text][et_pb_text admin_label=”References” module_class=”clearfix” _builder_version=”4.18.0″ _module_preset=”default” text_text_color=”#505050″ text_font_size=”16px” link_text_color=”#008C99″ link_font_size=”16px” header_5_font=”|600|||||||” header_5_text_align=”left” header_5_text_color=”#008c99″ custom_margin=”||3%||false|false” global_colors_info=”{}”]<\/p>\n 1. Pepper et al., \u201cThe High Cost of Epinephrine Autoinjectors and Possible Alternatives.\u201d J Allergy Clin Immunol Pract.<\/a>\u00a02017 May – Jun;5(3):665-668.<\/p>\n 2. Asthma and Allergy Foundation of America, \u201cMy Life With Asthma:\u00a0 Survey Overview (2017). 14.<\/p>\n [\/et_pb_text][et_pb_code admin_label=”Print” module_id=”print” module_class=”clearfix” _builder_version=”4.17.6″ _module_preset=”default” saved_tabs=”all” global_colors_info=”{}” global_module=”5156″ theme_builder_area=”post_content”]\n
References<\/h5>\n